<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03125850</url>
  </required_header>
  <id_info>
    <org_study_id>Zhongshan OC</org_study_id>
    <nct_id>NCT03125850</nct_id>
  </id_info>
  <brief_title>Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients</brief_title>
  <official_title>Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongshan Ophthalmic Center, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongshan Ophthalmic Center, Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the glaucoma day-ward patients' efficacy with inpatients by
      evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the
      differences. Half of participants will receive treatment in day-ward, while the other half
      will receive treatment in hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ophthalmic surgery has short operative time, quick recovery, and small anesthesia risk,
      making day case surgery the main management mode of ophthalmic surgery. This study will
      explore the differences of psychology and glaucoma knowledge between glaucoma day-ward
      patients and the inpatients. The data will be collected by scale on admission and discharge.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2017</start_date>
  <completion_date type="Actual">January 10, 2018</completion_date>
  <primary_completion_date type="Actual">December 10, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of depression and anxiety score</measure>
    <time_frame>at baseline and 1 hour before discharge</time_frame>
    <description>The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of glaucoma knowledge score</measure>
    <time_frame>at baseline and 1 hour before discharge</time_frame>
    <description>The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>day-ward group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>inpatient group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>randomized to day ward</intervention_name>
    <description>Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge</description>
    <arm_group_label>day-ward group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>randomized to inpaitent</intervention_name>
    <description>Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge</description>
    <arm_group_label>inpatient group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is diagnosed with glaucoma;

          2. Will receive glaucoma surgery;

          3. Voluntary participation in this study;

          4. Have enough language comprehension ability;

          5. Best corrected visual acuity reach 0.1 or better;

          6. Patient or his legal representative has sign the informed consent.

        Exclusion Criteria:

          1. Patient with mental disorder;

          2. There are important viscera function failure or other serious disease, including
             clinical related coronary artery disease, cardiovascular disease or myocardial
             infarction into the group of the first six months; serious neurological or psychiatric
             illness; serious infections; coagulant function abnormality; general active infectious
             diseases; malignant tumor; serious immune diseases;

          3. Patient with monocular blindness;

          4. Axial lengthâ‰¤20 mm;

          5. With other serious eye diseases;

          6. Neurologic diseases that could affect the visual field;

          7. 3 months prior to research to participate in any clinical study;

          8. Researchers think not suitable to participate in this clinical trial subjects;

          9. Refused to sign the informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingkai Lin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-San University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-San Univerdity</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 16, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Mingkai Lin</investigator_full_name>
    <investigator_title>chief physician</investigator_title>
  </responsible_party>
  <keyword>knowledge</keyword>
  <keyword>psychology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

